Prof. Dr. YUSUF BARAN

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Precision medicine in oncology: Challenges, stakes and new paradigms

Cox S., Rousseau-Tsangaris M., Abou-Zeid N., Dalle S., Leurent P., Cutivet A., et al.

BULLETIN DU CANCER , cilt.106, sa.2, ss.97-104, 2019 (SCI-Expanded)

An answer to colon cancer treatment by mesenchymal stem cell originated from adipose tissue

İPLİK E. S., Ertugrul B., KOZANOĞLU İ., BARAN Y., Cakmakoglu B.

IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES , cilt.21, sa.5, ss.465-468, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

Flow cytometry: basic principles and applications

ADAN A., Alizada G., Kiraz Y., Baran Y., Nalbant A.

CRITICAL REVIEWS IN BIOTECHNOLOGY , cilt.37, sa.2, ss.163-176, 2017 (SCI-Expanded)

Effects of cell-mediated osteoprotegerin gene transfer and mesenchymal stem cell applications on orthodontically induced root resorption of rat teeth

AMUK N., KURT G., BARAN Y., SEYRANTEPE V., YANDIM M., ADAN A., et al.

EUROPEAN JOURNAL OF ORTHODONTICS , ss.1-8, 2016 (SCI-Expanded)

Major apoptotic mechanisms and genes involved in apoptosis

KIRAZ Y., ADAN A., Yandim M. K., BARAN Y.

TUMOR BIOLOGY , cilt.37, sa.7, ss.8471-8486, 2016 (SCI-Expanded)

Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model

IŞıK S., KARAMAN M., ADAN A., KıRAY M., BAĞRıYANıK H., SÖZMEN Ş., et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , cilt.274, sa.1, ss.197-207, 2016 (SCI-Expanded)

Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling

ADAN A., BARAN Y.

TUMOR BIOLOGY , cilt.37, sa.5, ss.5781-5795, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

Apoptotic effects of non-edible parts of Punica granatum on human multiple myeloma cells.

KİRAZ Y., NEERGHEEN-BHUJUN V., RUMMUN N., BARAN Y.

TUMOR BIOLOGY , cilt.37, sa.1, ss.1802-1815, 2016 (SCI-Expanded)

Flow cytometry: basic principles and applications

ADAN A., ALIZADA G., KIRAZ Y., BARAN Y., NALBANT A.

CRITICAL REVIEWS IN BIOTECHNOLOGY , cilt.37, sa.2, ss.163-176, 2016 (SCI-Expanded)

Cell Proliferation and Cytotoxicity Assays

ADAN A., KIRAZ Y., BARAN Y.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY , cilt.17, sa.14, ss.1213-1221, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

T cells in Tumor Microenvironment

KİRAZ Y., BARAN Y., NALBANT A.

TUMOR BIOLOGY , cilt.37, sa.1, ss.39-45, 2016 (SCI-Expanded)

The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks

ADAN A., BARAN Y.

TUMOR BIOLOGY , cilt.36, sa.11, ss.8973-8984, 2015 (SCI-Expanded)

Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A

Kaymaz B. T., Gunel N. S., Ceyhan M., Cetintas V. B., Ozel B., Yandim M. K., et al.

TUMOR BIOLOGY , cilt.36, sa.10, ss.7915-7927, 2015 (SCI-Expanded)

A Novel Natural Product, KL-21, Inhibits Proliferation and Induces Apoptosis in Chronic Lymphocytic Leukemia Cells

ADAN A., YAŞAR M., BARAN Y.

TURKISH JOURNAL OF HEMATOLOGY , cilt.32, sa.2, ss.118-126, 2015 (SCI-Expanded)

Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line

Tufekci O., Yandim M. K., Oren H., Irken G., Baran Y.

LEUKEMIA RESEARCH , cilt.39, sa.3, ss.342-347, 2015 (SCI-Expanded)

An update on molecular biology and drug resistance mechanisms of multiple myeloma.

MUTLU P., KİRAZ Y., GÜNDÜZ U., BARAN Y.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.96, sa.3, ss.413-424, 2015 (SCI-Expanded)

Molecular mechanisms of drug resistance and its reversal in cancer

BARAN Y., Adan Gökbulut A., Kartal Yandım M.

CRITICAL REVIEWS IN BIOTECHNOLOGY , sa.11, ss.1-11, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Comparative development of knowledge-based bioeconomy in the European Union and Turkey

Ozan D. C., Baran Y.

CRITICAL REVIEWS IN BIOTECHNOLOGY , cilt.34, sa.3, ss.269-280, 2014 (SCI-Expanded)

Molecular Mechanisms of Quercitrin-induced Apoptosis in Non-small Cell Lung Cancer

Cincin Z. B., Unlu M., Kiran B., Bireller E. S., Baran Y., Cakmakoglu B.

ARCHIVES OF MEDICAL RESEARCH , cilt.45, sa.6, ss.445-454, 2014 (SCI-Expanded)

An update on molecular biology of thyroid cancers

ÖMÜR Ö., Baran Y.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.90, sa.3, ss.233-252, 2014 (SCI-Expanded)

Bioactive, functional and edible film-forming properties of isolated hazelnut (Corylus avellana L.) meal proteins

Aydemir L. Y., Adan A., Baran Y., Yemenicioglu A.

FOOD HYDROCOLLOIDS , cilt.36, ss.130-142, 2014 (SCI-Expanded)

Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells

Solmaz S., Adan A., Cincin B., Ozdogu H., Boga C., Cakmakoglu B., et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.66, sa.4, ss.599-612, 2014 (SCI-Expanded)

Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma

ÖMÜR Ö., Baran Y., ORAL A., Ceylan Y.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.20, sa.2, ss.185-192, 2014 (SCI-Expanded)

Multidrug resistance in chronic myeloid leukemia

Unlu M., Kiraz Y., Kaci F. N., Ozcan M. A., Baran Y.

TURKISH JOURNAL OF BIOLOGY , cilt.38, sa.6, ss.806-816, 2014 (SCI-Expanded)

5-Fluorouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells

Can G., Akpinar B., Baran Y., Zhivotovsky B., Olsson M.

ONCOGENE , cilt.32, sa.38, ss.4529-4538, 2013 (SCI-Expanded)

STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells

Kiper H. D., Kaymaz B. T., Adan A., Selvi N., Avci C. B., Kosova B., et al.

BIOMEDICINE & PHARMACOTHERAPY , cilt.67, sa.6, ss.527-532, 2013 (SCI-Expanded)

The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells

Bozkurt S., Ozkan T., ÖZMEN F., Baran Y., Sunguroglu A., Kansu E.

HEMATOLOGY , cilt.18, sa.4, ss.217-223, 2013 (SCI-Expanded)

Autologous rabbit adipose tissue-derived mesenchymal stromal cells for the treatment of bone injuries with distraction osteogenesis

Sunay O., Can G., Cakir Z., Denek Z., Kozanoglu I., Erbil G., et al.

CYTOTHERAPY , cilt.15, sa.6, ss.690-702, 2013 (SCI-Expanded)

Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance

Camgoz A., Gencer E. B., Ural A. U., Baran Y.

LEUKEMIA & LYMPHOMA , cilt.54, sa.6, ss.1279-1287, 2013 (SCI-Expanded)

Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest

Adan A., Apohan E., Baran Y.

HEMATOLOGY , cilt.18, sa.3, ss.144-150, 2013 (SCI-Expanded)

Changes in protein profiles of multiple myeloma cells in response to bortezomib

Turan T., Sanli-Mohamed G., Baran Y.

LEUKEMIA & LYMPHOMA , cilt.54, sa.5, ss.1061-1068, 2013 (SCI-Expanded)

Gossypol Interferes with Both Type I and Type II Topoisomerase Activities Without Generating Strand Breaks

Senarisoy M., Canturk P., Zencir S., Baran Y., TOPÇU Z.

CELL BIOCHEMISTRY AND BIOPHYSICS , cilt.66, sa.1, ss.199-204, 2013 (SCI-Expanded)

miR-17 in imatinib resistance and response to tyrosine kinase inhibitors in chronic myeloid leukemia cells

Firatligil B., Avci C. B., Baran Y.

JOURNAL OF BUON , cilt.18, sa.2, ss.437-441, 2013 (SCI-Expanded)

The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopy

Baran Y., Ceylan C., Camgoz A.

BIOMEDICINE & PHARMACOTHERAPY , cilt.67, sa.3, ss.221-227, 2013 (SCI-Expanded)

New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma

Kozanoglu I., Yandim M. K., Cincin Z. B., Ozdogu H., Cakmakoglu B., Baran Y.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.139, sa.2, ss.327-335, 2013 (SCI-Expanded)

Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer

Adan-Gokbulut A., Kartal-Yandim M., Iskender G., Baran Y.

CURRENT MEDICINAL CHEMISTRY , cilt.20, sa.1, ss.108-122, 2013 (SCI-Expanded)

Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer

Yandim M. K., APOHAN E., Baran Y.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.71, sa.1, ss.13-20, 2013 (SCI-Expanded)

Macromolecular Changes in Nilotinib Resistant K562 Cells; an In vitro Study by Fourier Transform Infrared Spectroscopy

Ceylan C., Camgoz A., Baran Y.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT , cilt.11, sa.4, ss.333-344, 2012 (SCI-Expanded)

Enalapril-induced Apoptosis of Acute Promyelocytic Leukaemia Cells Involves STAT5A

Purclutepe O., Iskender G., Kiper H. D., Tezcanli B., Selvi N., Avci C. B., et al.

ANTICANCER RESEARCH , cilt.32, sa.7, ss.2885-2893, 2012 (SCI-Expanded)

Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells

Bassoy E. Y., Baran Y.

BIOMEDICINE & PHARMACOTHERAPY , cilt.66, sa.2, ss.103-110, 2012 (SCI-Expanded)

Role of autophagy in the progression and suppression of leukemias

Ekiz H. A., Can G., Baran Y.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.81, sa.3, ss.275-285, 2012 (SCI-Expanded)

Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition

Baran Y., Zencir S., Cakir Z., ÖZTÜRK E., TOPÇU Z.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , cilt.36, sa.6, ss.673-679, 2011 (SCI-Expanded)

A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes

Gencer E. B., URAL A. U., AVCU F., Baran Y.

ANNALS OF HEMATOLOGY , cilt.90, sa.11, ss.1265-1275, 2011 (SCI-Expanded)

The roles of antiapoptotic sphingosine kinase-1 and glucosylceramide genes in drug induced cell death of MCF-7 breast cancer cells

Gucluler G., Piskin O., Baran Y.

JOURNAL OF BUON , cilt.16, sa.4, ss.646-651, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells

Avci C. B., Yilmaz S., Dogan Z. O., SAYDAM G., Dodurga Y., Ekiz H. A., et al.

HEMATOLOGY , cilt.16, sa.5, ss.303-307, 2011 (SCI-Expanded)

Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma

Firinci F., Karaman M., Baran Y., Bagriyanik A., AYYILDIZ Z. A., Kiray M., et al.

INTERNATIONAL IMMUNOPHARMACOLOGY , cilt.11, sa.8, ss.1120-1126, 2011 (SCI-Expanded)

Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloidleukemia cells

Camgoz A., Gencer E. B., Ural A. U., AVCU F., Baran Y.

LEUKEMIA & LYMPHOMA , cilt.52, sa.8, ss.1574-1584, 2011 (SCI-Expanded)

Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A

Salas A., Ponnusamy S., SENKAL C. E., Meyers-Needham M., Selvam S. P., Saddoughi S. A., et al.

BLOOD , cilt.117, sa.22, ss.5941-5952, 2011 (SCI-Expanded)

Bioactive Sphingolipids in Response to Chemotherapy: A Scope on Leukemias

Ekiz H. A., Baran Y.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , cilt.11, sa.4, ss.385-397, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells

Can G., Ekiz H. A., Baran Y.

HEMATOLOGY , cilt.16, sa.2, ss.95-99, 2011 (SCI-Expanded)

The importance of protein profiling in the diagnosis and treatment of hematologic malignancies

Sanli-Mohamed G., Turan T., EKIZ H. A., Baran Y.

TURKISH JOURNAL OF HEMATOLOGY , cilt.28, sa.1, ss.1-14, 2011 (SCI-Expanded)

Journal of Cancer Research and Clinical Oncology Volume 137, Issue 2, February 2011, Pages 279-286 The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells

BARAN Y., Çakır Z., Saydam G., Şahin F.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , sa.137, ss.279-286, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells

Avci C. B., GÜNDÜZ C., Baran Y., ŞAHİN F., Yilmaz S., Dogan Z. O., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.137, sa.1, ss.41-47, 2011 (SCI-Expanded)

Resveratrol Triggers Apoptosis Through Regulating Ceramide Metabolizing Genes in Human K562 Chronic Myeloid Leukemia Cells

Kartal M., SAYDAM G., ŞAHİN F., Baran Y.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.63, sa.4, ss.637-644, 2011 (SCI-Expanded)

Therapeutic applications of bioactive sphingolipids in hematological malignancies

Ekiz H. A., Baran Y.

INTERNATIONAL JOURNAL OF CANCER , cilt.127, sa.7, ss.1497-1506, 2010 (SCI-Expanded)

Proteasome Inhibitor Bortezomib Increases Radiation Sensitivity in Androgen Independent Human Prostate Cancer Cells

GOKTAS S., Baran Y., URAL A. U., YAZICI S., AYDUR E., BASAL S., et al.

UROLOGY , cilt.75, sa.4, ss.793-798, 2010 (SCI-Expanded)

Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells

GUCLULER G., Baran Y.

HEMATOLOGY , cilt.14, sa.3, ss.139-144, 2009 (SCI-Expanded)

Bisphosphonate treatment and radiotherapy in metastatic breast cancer

URAL A. U., AVCU F., Baran Y.

MEDICAL ONCOLOGY , cilt.25, sa.3, ss.350-355, 2008 (SCI-Expanded)

Cytotoxic effects of four different endodontic materials in human periodontal ligament fibroblasts

GÖRDUYSUS M., AVCU N., Gorduysus O., PEKEL A., Baran Y., AVCU F., et al.

JOURNAL OF ENDODONTICS , cilt.33, sa.12, ss.1450-1454, 2007 (SCI-Expanded)

Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance

Baran Y., Guer B., Kaya P., Ural A. U., AVCU F., Guenduez U.

HEMATOLOGY , cilt.12, sa.6, ss.511-517, 2007 (SCI-Expanded)

Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells

BARAN Y., Salas A., Senkal C. E., Gündüz U., Bielawski J., Obeid L., et al.

JOURNAL OF BIOLOGICAL CHEMISTRY , cilt.282, sa.15, ss.10922-10934, 2007 (SCI-Expanded)

Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF

ONALAN G., SELAM B., Baran Y., CINCIK M., ONALAN R., GUNDUZ U., et al.

HUMAN REPRODUCTION , cilt.20, sa.9, ss.2391-2395, 2005 (SCI-Expanded)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Multidrug resistance mechanisms in hematological malignencies

KİRAZ Y., ADAN A., BARAN Y.

FRONTIERS IN SCIENTIFIC RESEARCH-TWAS, Bangalore, Hindistan, 21 - 22 Aralık 2015, ss.1

THE MICROARRAY GENE PROFILING ANALYSIS OF ACUTEPROMYELOCYTIC LEUKEMIA CELLS IN RESPONSE TO FISETIN AND HESPERETIN

ADAN A., BARAN Y.

20TH Congress of THE European Hematology Association, Viyana, Avusturya, 11 Haziran - 14 Ekim 2015, ss.651

Multidrug Resistance Mechanisms in Leukemias

BARAN Y., KİRAZ Y., ADAN A.

Future of Biomedicine Conference 2015, Vladivostok, Rusya, 2 - 07 Eylül 2015, ss.53

Therapeutic potential of fisetin and identification of its mechanisms in action in chronic myeloid leukemia and acute promyelocytic leukemia cells

ADAN A., BARAN Y.

40TH FEBS CONGRESS, Berlin, Almanya, 4 - 09 Temmuz 2015, ss.241

SPHINGOSINE-1-PHOSPHATE RECEPTOR 2/GQ/PHOSPHOLIPASE C AXIS IS A NOVEL MECHANISM TO OVERCOME NILOTINIB RESISTANCE IN T315I MUTATION EXPRESSING 32DCL3 MURINE CELLS

ADAN A., OGRETMEN B., BARAN Y.

20TH Congress of the European Hematology Association, Viyana, Avusturya, 11 - 14 Haziran 2015, ss.428

A GENOME-WIDE ANALYSES OF DIFFERENTIALLY EXPRESSED GENES AND RELATED NETWORKS AFFECTED BY FISETIN AND HESPERETIN IN CHRONIC MYELOID LEUKEMIA CELLS

ADAN A., BARAN Y.

20th Congress of the European Hematology Association, Viyana, Avusturya, 11 - 14 Haziran 2015, ss.686

Revealing Genome Wide mRNA and miRNA Expression Profiles in Parental and Imatinib Resistant Chronic Myeloid Leukemia Cells

TEZCANLI KAYMAZ B., SELVİ GÜNEL N., CEYHAN M., BOZOK ÇETİNTAŞ V., KARTAL YANDIM M., ÖZEL B., et al.

V. INTERNATIONAL CONGRESS OF MOLECULAR MEDICINE, İzmir, Türkiye, 20 - 22 Mayıs 2015, ss.176

Targeting STAT3 has therapeutic potential to regain nilotinib response in parental and resistant chronic myeloid leukemia cells

TEZCANLI KAYMAZ B., SELVİ GÜNEL N., BOZOK ÇETİNTAŞ V., ADAN A., BARAN Y., GÜNDÜZ C., et al.

EACR-Sponsored 3rd Anticancer Agent Development Congress, İzmir, Türkiye, 18 - 19 Mayıs 2015, ss.182

OVERCOMING NILOTINIB RESISTANCE BY SPECIFIC INHIBITION OF SPHINGOSINE-1-. PHOSPHATE RECEPTOR 2/GQ/ PHOSPHOLIPASE C AXIS IN CHRONIC MYELOID LEUKEMIA

ADAN A., OGRETMEN B., BARAN Y.

International Ceramide Conference, İzmir, Türkiye, 6 - 10 Mayıs 2015, ss.85

HESPERETİN ARACILI APOPTOZDA ROLÜ OLAN SİNYAL YOLAKLARıNIN AKUT MYELOİD LÖSEMİ VE KRONİK MYELOİD LÖSEMİ HÜCRELERİNDE TÜM GENOM MİKROARRAY ANALİzİ İLE SAPTANMASI

ADAN A., BARAN Y.

2. ULUSLARARASI KA TILIMLI DENEYSEL HEMA TOLOJİ KONGRESİ, Kayseri, Türkiye, 17 - 19 Nisan 2015, ss.10

FİSETİN TARAFINDAN MODÜLE EDİLEN GEN VE GENETİK YOLAKLARIN AKUT MİYELOİD LÖSEMİ VE KRONİK MYLEOİD LÖSEMİ HÜCRELERİNDE TÜM GENOM MİKROARRAY ANALİzİ İLE SAPTANMASI

ADAN A., BARAN Y.

2. ULUSLARARASI KA TILIMLI DENEYSEL HEMA TOLOJİ KONGRESİ, Kayseri, Türkiye, 17 - 19 Nisan 2015, ss.32

Metrikler

Yayın

Atıf (WoS)

1910

H-İndeks (WoS)

Atıf (Scopus)

1962

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim